We have recently identified cyclin G as being overexpressed in breast cancer cells using differential screening. We found that cyclin G overexpression was a frequent occurrence in human breast cancer specimens. Cyclin G, a recent addition to the cyclin family, was identified as a transcriptional target of the tumor suppressor, p53. Although the biological role(s) of cyclin G has not yet been defined, transactivation of cyclin G by p53 is intriguing since other cyclins have been shown to play crucial roles in the control of cell cycle and growth. Transcriptional induction of cyclin G by p53 was only observed in normal or non-tumorigenic cells. Preliminary data suggest that following DNA damage in normal mammary epithelial cells, as well as in fibroblasts, cyclin G is triggered to cluster in discrete nuclear DNA replication foci that contain replication-associated proteins such as PCNA. Initial characterization of cyclin G suggests that there is a link between p53-mediated tumor suppression and DNA replication. Additionally, we observed that retrovirus-mediated overexpression of cyclin G induced cell cycle arrest in 10.1 fibroblasts, which contain no p53, suggesting that overexpression of cyclin G in p53-null cells mimics the tumor suppressive role of p53. The overall goal of this revised project is to characterize the phenotypic changes and the undefined role(s) of cyclin G related to mammary cell proliferation in vitro and in vivo. We will also analyze the molecular basis of increased transcription of cyclin G in breast cancer cells by further localizing the responsive region of the cyclin G promoter. In addition, we will determine whether the enhanced protein stability of cyclin G can contribute to cyclin G overexpression in breast cancer cells by using a chimeric molecule with cyclin G fused to luciferase protein. A variety of p53 mutants will be analyzed in an effort to identify and define p53 determinants required for cyclin G induction. Lastly, we will generate transgenic mice, expressing cyclin G, and cross these mice with other existing cyclin transgenic mice including cyclin D, p2 1-/-, and ErbB2-overexpressing mice as well as p53 null mice to identify the role of cyclin G in vivo. Better understanding of the roles of cyclin G in cell growth control should offer a unique opportunity to study a novel mechanism for p53-mediated tumor suppression and also develop a novel approach targeting for mammary cell transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA085681-02
Application #
6514436
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Spalholz, Barbara A
Project Start
2001-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$267,750
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
(2013) Retraction notice to: GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell 51:552
Brown-Endres, Lauren; Schoenfeld, David; Tian, Fang et al. (2012) Expression of the p53 target CDIP correlates with sensitivity to TNFýý-induced apoptosis in cancer cells. Cancer Res 72:2373-82
Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U et al. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231-4
Mandinova, Anna; Lee, Sam W (2011) The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med 3:64rv1
Benson, Erica K; Lee, Sam W; Aaronson, Stuart A (2010) Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence. J Cell Sci 123:2605-12
Tian, Fang; Lee, Sam W (2010) X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma. J Invest Dermatol 130:2169-72
Carrera, Samantha; de Verdier, Petra J; Khan, Zahid et al. (2010) Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis. J Biol Chem 285:13658-65
Zhao, Bo; Benson, Erica K; Qiao, Ruifang et al. (2009) Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice. EMBO Rep 10:71-8
Ide, Takao; Brown-Endres, Lauren; Chu, Kiki et al. (2009) GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell 36:379-92
Das, Sanjeev; Boswell, Sarah A; Aaronson, Stuart A et al. (2008) P53 promoter selection: choosing between life and death. Cell Cycle 7:154-7

Showing the most recent 10 out of 17 publications